Trending Now
Business
Ta-Nehisi Coates Steals Content From Trump And The GE
The art world is all topsy turvy right now. Artists are creating new ways of dissecting the world, debating about it, vetting...
Can Valeant Overcome The Rifamycin Threat?
Cosmo Pharmaceuticals (CMOPF) announced it submitted a New Drug Applicaton ("NDA") for Rifamycin to the FDA for approval to treat traveler's diarrhea under an...
Lifestyle today
Entertainment
Mohawk Tribe Seeks To Dismiss Allergan Patent Case; Where Is Sherrod Brown?
The fight to protect Allergan's (AGN) Restasis patents is heating up. Friday the St. Regis Mohawk Tribe filed to have Mylan's (MYL) challenge to...
What Is Teva Hiding From Senator McCaskill?
Tuesday Senator Claire McCaskill lambasted Teva (TEVA) for stonewalling her inquiry into the company's development and sales of opioids:
U.S. Senator Claire McCaskill blasted Teva...
Did GE Shock Investors?
General Electric (GE) held its Investor Day earlier this month and the event was shocking to say the least. First of all, with the...
‘Shock Exchange’ Predicted General Electric’s Demise, But No One Listened
General Electric nearly collapsed in 2009 after the commercial paper market cratered. GE had to beg President Obama for a taxpayer bailout to protect...
Maria Chappelle-Nadal Demands Mental Health Screening For Trump
Missouri State Representative Maria Chappelle-Nadal is arguably the country's leading black politician. She continues to stand for African-Americans, poor people and those who do...
Endo On Pace For $1 Billion In Pre-Mesh Cash Flow
Endo International (ENDP) remains one of the market's most frustrating, confounding stocks. The stock hit a high of over $18 in the second half...
‘Trump And The GE’ Explains The Folly Of Obama’s Trickle-Down Economics
Trump And The GE Does NY Fashion Week featured Senator Maria Chappelle-Nadal, Torian Mitchell (AYCE Network), and Shock Exchange. The event took place in...
Drug Companies Say Enough Agree To $26 Billion Opioid Settlement
Former president Donald Trump was highly critical of opioid drug manufacturers. He wanted to shed more light on their role in the...























































































































